OKT3 induction in 100 consecutive pancreas transplants.
Stratta
R J
RJ
Department of Surgery, University of Nebraska Medical Center, Omaha 68198-3280.
Taylor
R J
RJ
Lowell
J A
JA
Bynon
J S
JS
Cattral
M S
MS
Frisbie
K
K
Miller
S
S
Brennan
D C
DC
D003922:Diabetes Mellitus, Type 1 / Q000601:surgery; D005434:Flow Cytometry; D005500:Follow-Up Studies; D006085:Graft Survival; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods; D016030:Kidney Transplantation / Q000276:immunology*; D016853:Muromonab-CD3 / Q000627:therapeutic use*; D016035:Pancreas Transplantation / Q000276:immunology* / Q000401:mortality; D012307:Risk Factors; D015996:Survival Rate; D016176:T-Lymphocyte Subsets / Q000276:immunology; D013997:Time Factors
D016853:Muromonab-CD3